-
COVID-19 vaccine immunogenicity and population-based outcome studies in patients with hematologic malignancies
Hofsink, Q., 2025, 230 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
-
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
COBRA KAI Study Team, 1 Jul 2023, In: EClinicalMedicine. 61, 102040.Research output: Contribution to journal › Article › Academic › peer-review
-
Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: a randomized, controlled trial
Huygens, S., Hofsink, Q., Nijhof, I. S., Goorhuis, A., Kater, A. P., Te Boekhorst, P. A., Swaneveld, F., Novotný, V. M., Bogers, S., Welkers, M. R., Papageorgiou, G., Rijnders, B. J. & Heijmans, J., 15 Jan 2023, In: The Journal of infectious diseases. 227, 2, p. 206-210 5 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
